UnknownNot Applicable

Thoracic Fluid Content by Electric Bioimpedance Versus Lung Ultrasound in Preterm Neonates With Respiratory Distress

Egypt70 participantsStarted 2022-11-01

Plain-language summary

A prospective cohort study aims to evaluate the predictive value of thoracic fluid content measured by electric bioimpedance for detecting the need for surfactant administration or positive pressure ventilation requirement; whether invasive or non-invasive; in preterm neonates with respiratory distress and to compare it to lung ultrasound.

Who can participate

Age range1 Minute – 3 Days

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Preterm neonates with gestational age ≤ 34 weeks, admitted with respiratory distress: Defined as the presence of at least two of the following clinical symptoms: Tachypnea, grunting, retractions (subcostal, intercostal, suprasternal), nasal flaring and other symptoms include apnea, bradypnea, irregular (seesaw) breathing, inspiratory stridor, wheezes and hypoxia Exclusion Criteria: * Preterm neonates with evidence of any of the following: Chromosomal anomalies Mechanical ventilation or received endotracheal surfactant before first assessment

What they're measuring

predictive value of thoracic fluid content measurement for detecting the need for surfactant administration or positive pressure ventilation requirement in preterm neonates with respiratory distress and to compare it to lung ultrasound.

Timeframe: 72 hours

Trial details

NCT IDNCT05594030

SponsorAin Shams University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-11

Contact for this trial

mohamed Khalifa, MD

01010736078 drkhalifa2233@gmail.com

View on ClinicalTrials.gov More Respiratory Distress Syndrome, Newborn trials